Cargando…
Identification of a real-world clinical model associated with atrial fibrillation in a large french primary care database
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Private company. Main funding source(s): Bristol Myers Squibb and Pfizer. BACKGROUND: Undiagnosed atrial fibrillation (AF) is associated with a higher risk of stroke and mortality. To date, the 2020 European Society of Cardiology (ESC) guidelines re...
Autores principales: | Sabouret, S P F, Leclercq, L C, Tamberou, C T, Cortinovis, C L, Moniot, M A, Deharo, D J C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207354/ http://dx.doi.org/10.1093/europace/euad122.208 |
Ejemplares similares
-
Racial differences in atrial fibrillation-related strokes and mortality
por: Kang, D S, et al.
Publicado: (2023) -
Racial differences in atrial fibrillation-related bleeding and mortality
por: Kang, D S, et al.
Publicado: (2023) -
Baseline characteristics of edoxaban treatment in routine clinical practice for patients with non-valvular atrial fibrillation in China (ETNA-AF-China)
por: Guo, X Y, et al.
Publicado: (2023) -
Omitting transesophageal echocardiography before catheter ablation of atrial fibrillation or left sided atrial tachycardia in patients on oral anticoagulation
por: Maslova, V, et al.
Publicado: (2023) -
The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study
por: Grymonprez, M, et al.
Publicado: (2023)